Filter results by document type and/or working area to find what you're searching for.
Determining the aetiology of thrombocytopenia is of major importance. The immature platelet fraction (IPF) can help you promptly differentiate between ineffective bone marrow production and increased destruction or consumption of platelets. Find out more about the use of this parameter here.
The treatment of immune thrombocytopenia (ITP) can be challenging. The immature platelet count (IPF#) can help, making it easier to monitor the efficacy of the different treatment mechanisms and assessing bleeding risks. This white paper explains how.
A deeper insight about an activation of the immune response of patients can be acquired from newly available diagnostic parameters that support differentiation between inflammation and infection, different pathogenic causes of infection (viral versus bacterial) and different types of immune response: early innate, cellular or humoral immune response.
In daily clinical practice, the treating physician is flooded by the vast amount of available lab parameters and data from which the results relevant to each particular medical case need to be selected. The XE-5000 Case Manager embodies a new concept in diagnostics – one that combines proven Sysmex fluorescence flow cytometry with case-related clinical data.
The XS-1000i and the XS-800i, suitable for minimal sample throughput, are part of the X-Class, whose outstanding feature is the unique system of fluorescence flow cytometry for white blood cell (WBC) differentiation. We would like to present the experience gained with XS-series with a focus on paediatric blood analyses.
Specially tailored to the requirements of small laboratories with low sample volumes or as backup systems, the XS-1000i and XS-800i are offering proven technology and handling of the X-Class coupled with innovative changes.
Sysmex XS-series haematology analysers are tailored specifically to the requirements of small laboratories with low sample volumes, or as backup systems where users do not wish to compromise in terms of result quality. This is especially relevant in today’s demanding haematology environment.